Thyroid storm after intensity-modulated radiation therapy: A case report and discussion

Oncologist

Volumn 14, Issue 3, 2009, Pages 233-239

  Diaz, Roberto ^a   Blakey, Marc D ^a   Murphy, Patrick B ^b   Cryar, A Keith ^c   Cmelak, Anthony J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Tennessee Oncology   (United States)

^c Maury Regional Hospital   (United States)

Author keywords

Head and neck cancer; IMRT; Thyroid storm; Thyrotoxicosis

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; LEVOTHYROXINE; PACLITAXEL; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; DEHYDRATION; DRUG DOSE INCREASE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYPERTHYROIDISM; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; STOMATITIS; THYROID CRISIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TONGUE CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; MALE; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; THYROID CRISIS; THYROID HORMONES; TONGUE NEOPLASMS;

EID: 64049091897     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0156     Document Type: Article

References (24)

1. Posner MR, Hershock DM, Blajman CR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357: 1705-1715.
2. Vermorken JB, Remenar E, van Herpen C et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357: 1695-1704.
3. Diaz R, Thorpe SW, Murphy BA et al. Intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC): Toxicities and efficacy. Int J Radiat Oncol 2007;69:S464-S464.
4. McDermott MT, Kidd GS, Dodson LE Jr et al. Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 1983;75:353-359.
5. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am 2006;35:663-686, vii.
6. Pimentel L, Hansen KN. Thyroid disease in the emergency department: A clinical and laboratory review. J Emerg Med 2005;28:201-209.
7. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993;22:263-277.
8. Brooks MH, Waldstein SS. Free thyroxine concentrationsin thyroid storm. Ann Intern Med 1980;93:694-697.
9. Krishnamurthy GT, Blahd WH. Case reports. Hyperthyroidism in the presence of panhypopituitarism. Thyroid crisis and hypothyroidism following radioiodine treatment. West J Med 1974;120:491-496.
10. Pacini F, Vorontsova T, Molinaro E et al. Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatr Suppl 1999;88:23-27.
11. Vermiglio F, Castagna MG, Volnova E et al. Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. Thyroid 1999;9:781- 786.
12. Marur S, Forastiere AA. Head and neck cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:489 -501.
13. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
14. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165-1170.
15. Jereczek-Fossa BA, Alterio D, Jassem J et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369-384.
16. Nishiyama K, Kozuka T, Higashihara T et al. Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 1996;36:1221-1224.
17. Nishiyama K, Tanaka E, Tarui Y et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys 1996;34:439 -444.
18. Constine LS, Donaldson SS, McDougall IR et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984;53:878-883.
19. Yoden E, Soejima T, Maruta T et al. [Hypothyroidism after radiotherapy to the neck]. Nippon Igaku Hoshasen Gakkai Zasshi 2004;64:146-150. In Japanese.
20. Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol 2000;57:97-101.
21. Diaz R, Jaboin J, Stinson S et al. Hypothyroidism as a consequence of intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC). Presented atthe 2008 AmericanSociety ofClinical Oncology Annual Meeting, Chicago, IL, May 30-June 3, 2008.
22. CaglarHB, Allen AM. Intensity-modulated radiotherapy forhead and neck cancer. Clin Adv Hematol Oncol 2007;5:425-431.
23. Lee N, Puri DR, Blanco AI et al. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 2007;29:387-400.
24. Mendenhall WM, AmdurRJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 2006;24:2618-2623.